Correction of Anemia in Chronic Kidney Disease With Angelica sinensis Polysaccharide via Restoring EPO Production and Improving Iron Availability

Given the limited efficacy and potential disadvantages of erythropoiesis-stimulating agents (ESAs) in treating anemia of chronic kidney disease (CKD), the development of better alternative therapies has become a priority. The primary purpose of this study is to investigate the effects of Angelica si...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kaiping, Wu, Jun, Xu, Jingya, Gu, Saisai, Li, Qiang, Cao, Peng, Li, Mingming, Zhang, Yu, Zeng, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079227/
https://www.ncbi.nlm.nih.gov/pubmed/30108502
http://dx.doi.org/10.3389/fphar.2018.00803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079227/
https://www.ncbi.nlm.nih.gov/pubmed/30108502
http://dx.doi.org/10.3389/fphar.2018.00803

Ejemplares similares